Photodynamic Therapy for Eye Cancer
AbstractPhotodynamic therapy is well-established as a treatment for a number of conditions in ophthalmology, principally in the field of medical retina, but less so in ocular oncology. Cancer of the eye is rare, the commonest lesions to affect the globe being choroidal melanoma (as a primary malignancy) and choroidal metastases (a secondary malignancy). The mainstay of treatment of such lesions remains radiotherapy in various forms, however, photodynamic therapy does have a useful role to play in the management of such patients. In this article, I hope to review the current indications, treatment regimes, and the risks and benefits of photodynamic therapy (PDT) as a treatment for eye cancer. View Full-Text
Share & Cite This Article
Rundle, P. Photodynamic Therapy for Eye Cancer. Biomedicines 2017, 5, 69.
Rundle P. Photodynamic Therapy for Eye Cancer. Biomedicines. 2017; 5(4):69.Chicago/Turabian Style
Rundle, Paul. 2017. "Photodynamic Therapy for Eye Cancer." Biomedicines 5, no. 4: 69.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.